Informatics Institute
Medication Safety Collaborative

[102-L05] Setting Your Agenda for Safety: Improving Handoffs, Embracing Pharmacogenomics, and Maximizing Your Current Program

Sunday, June 3
9:45 AM - 10:45 AM
Room: Mile High Ballroom 1, Level 3 (Lower Level)


ACPE Activity #0204-0000-18-102-L05-P
1.00 Contact Hours | Application-based

This program is approved for up to 1.00 continuing education (CE) hours for use in fulfilling the continuing education requirements of the Certified Professional in Healthcare Information & Management Systems (CPHIMS) or the Certified Associate in Healthcare Information and Management Systems (CAHIMS).

Learning Objectives:

Cynthia Von Heeringen, Pharm.D., M.S., BCPS, FASHP, R.Ph.

Director, Educational Programs II
ASHP
Bethesda, MD

I will be your ASHP point of contact as you plan your session. Please do not hesitate to contact me with any questions or concerns. I look forward to working with you.

Presentation(s):

Send Email for Cynthia Von Heeringen

James M. Hoffman, R.Ph., Pharm.D., M.S., BCPS, FASHP

Chief Patient Safety Officer, Associate Member, Pharmaceutical Sciences
St. Jude Children's Research Hospital
Memphis, TN

James M. Hoffman PharmD, MS is an Associate Member in Pharmaceutical Sciences and the Chief Patient Safety Officer at St. Jude Children’s Research Hospital in Memphis, Tennessee. His career is dedicated to evaluating and improving complex medication use systems and improving patient safety. Hoffman leads patient safety efforts across St. Jude where patients with catastrophic diseases routinely require complex care. Hoffman’s research focuses on patient safety culture, event detection, clinical decision support, and the clinical implementation of pharmacogenetics. At St. Jude, he has been involved in efforts related to all of these areas, and he has extensive experience leading change across St. Jude. For example, he collaborated closely with Clinical Informatics leaders to assess and manage alert fatigue in the St. Jude electronic health record (EHR) and design and implement advanced CDS, including pharmacogenomic CDS, to prevent patient harm and improve patient care for St. Jude patients. He is an investigator on St. Jude’s pharmacogenetic implementation effort (PG4KDS www.stjude.org/pg4kds) and provides national leadership through the Clinical Pharmacogenetic Implementation Consortium (CPIC https://cpicpgx.org) where he co-leads CPIC’s informatics working group.





Presentation(s):

Send Email for James Hoffman

Amy J. Starmer, Pharm.D., M.S., BCPS, FASHP, M.D., M.P.H.

Assistant Professor of Pediatrics
Boston Children's Hospital / Harvard Medical School
Boston, MA

Dr. Starmer works as a general pediatrician, as an Assistant Professor of Pediatrics at Harvard Medical School, and is the Director of Primary Care Quality Improvement and Associate Medical Director of Quality in the Department of Medicine at Boston Children’s Hospital. Dr. Starmer is a graduate of Haverford College and the University of Chicago Pritzker School of Medicine. She completed pediatric residency training at the University of North Carolina Chapel Hill, a fellowship in General Academic Pediatrics and Health Services Research at Boston Children’s Hospital, and received a Masters Degree from the Harvard School of Public Health in 2010. She served as the Project Leader for the I-PASS pilot study (JAMA 2013), the seminal multicenter I-PASS Study (New England Journal of Medicine 2014), and currently serves as the co-PI of the 32-institution Society for Hospital Medicine I-PASS Mentored Implementation Project. Through these roles, Dr. Starmer led the development of the I-PASS Handoff Program, serving as co-chair of the I-PASS Study Education Executive Committee, and has been directly responsible for overseeing the implementation and dissemination of the I-PASS Handoff Program in more than 50 institutions. Her work has been recognized through the receipt of multiple awards including the Ray E Helfer Award for Innovation in Medical Education Research and the 2016 John M. Eisenberg award for National Innovation in Patient Safety.

Presentation(s):

Send Email for Amy Starmer

James M. Hoffman, M.D., M.P.H., Pharm.D., M.S., BCPS, FASHP

Chief Patient Safety Officer, Associate Member, Pharmaceutical Sciences
St. Jude Children's Research Hospital
Memphis, TN

James M. Hoffman PharmD, MS is an Associate Member in Pharmaceutical Sciences and the Chief Patient Safety Officer at St. Jude Children’s Research Hospital in Memphis, Tennessee. His career is dedicated to evaluating and improving complex medication use systems and improving patient safety. Hoffman leads patient safety efforts across St. Jude where patients with catastrophic diseases routinely require complex care. Hoffman’s research focuses on patient safety culture, event detection, clinical decision support, and the clinical implementation of pharmacogenetics. At St. Jude, he has been involved in efforts related to all of these areas, and he has extensive experience leading change across St. Jude. For example, he collaborated closely with Clinical Informatics leaders to assess and manage alert fatigue in the St. Jude electronic health record (EHR) and design and implement advanced CDS, including pharmacogenomic CDS, to prevent patient harm and improve patient care for St. Jude patients. He is an investigator on St. Jude’s pharmacogenetic implementation effort (PG4KDS www.stjude.org/pg4kds) and provides national leadership through the Clinical Pharmacogenetic Implementation Consortium (CPIC https://cpicpgx.org) where he co-leads CPIC’s informatics working group.





Presentation(s):

Send Email for James Hoffman


Assets

[102-L05] Setting Your Agenda for Safety: Improving Handoffs, Embracing Pharmacogenomics, and Maximizing Your Current Program

Audio

MP3 Audio

Presentation Slides

Slides

Handouts

Handout

Synchronized Presentation + Audio

Presentation + Audio


Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Setting Your Agenda for Safety: Improving Handoffs, Embracing Pharmacogenomics, and Maximizing Your Current Program